Question 1

What is Amicus Therapeutics?

Accepted Answer

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases.

Question 2

What are some of the rare diseases that Amicus Therapeutics focuses on?

Accepted Answer

Amicus Therapeutics has a pipeline of programs focused on treating rare diseases such as Fabry disease, Pompe disease, and Batten disease. The company also has additional preclinical programs.

Question 3

What products does Amicus Therapeutics offer?

Accepted Answer

Amicus Therapeutics' product portfolio includes Galafold® (migalastat) for the treatment of Fabry disease and Pombiliti® + Opfolda® (cipaglucosidase alfa-atga) (miglustat) for the treatment of Pompe disease.

Question 4

How does Amicus Therapeutics ensure patient access to its medicines?

Accepted Answer

Amicus Therapeutics is committed to ensuring patient access to its medicines. The company has an expanded access program and works closely with patient advocacy groups to support the rare disease community.

Question 5

What is Amicus Therapeutics' approach to corporate responsibility?

Accepted Answer

Amicus Therapeutics takes a comprehensive approach to corporate responsibility, focusing on ethics and compliance, global medical affairs, corporate giving, and environmental, social, and governance (ESG) initiatives.

Amicus Therapeutics

Company Overview

Company Name

Address

Website

Approx. Annual Revenue

Employees

About Amicus Therapeutics

Frequently Asked Questions about Amicus Therapeutics

What is Amicus Therapeutics?

What are some of the rare diseases that Amicus Therapeutics focuses on?

What products does Amicus Therapeutics offer?

How does Amicus Therapeutics ensure patient access to its medicines?

What is Amicus Therapeutics' approach to corporate responsibility?

Advertising Pixels

Technologies Used

Social Profiles

Key Decision Makers